Genome-wide analysis of Schistosoma mansoni reveals limited population structure and possible praziquantel drug selection pressure within Ugandan hot-spot communities.

• Main Authors: Tushabe John Vianney (Author), Duncan J Berger (Author), Stephen R Doyle (Author), Geetha Sankaranarayanan (Author), Joel Serubanja (Author), Prossy Kabuubi Nakawungu (Author), Fred Besigye (Author), Richard E Sanya (Author), Nancy Holroyd (Author), Fiona Allan (Author), Emily L Webb (Author), Alison M Elliott (Author), Matthew Berriman (Author), James A Cotton (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Populations within schistosomiasis control areas, especially those in Africa, are recommended to receive regular mass drug administration (MDA) with praziquantel (PZQ) as the main strategy for controlling the disease. The impact of PZQ treatment on schistosome genetics remains poorly understood, and...